Revolutionizing Interventional Radiology with AI

We are proud to announce the launch of the SHERPA project in January 2025, an innovative European initiative designed to revolutionize interventional radiology (IR) by providing AI-powered assistive technologies that act as trusted companions for IR specialists.

In a field where specialists use advanced imaging to perform high-risk, minimally invasive procedures like treating brain aneurysms and liver tumors SHERPA aims to ease workloads, boost clinical accuracy, and improve patient outcomes.

Our Ambition Focuses On:

• Developing a comprehensive, yet tailored methodological framework to systematically assess the value of assistive technologies for the healthcare professionals, patients, and the healthcare system
• Enhancing staff focus and experience through automated image-guided workflows for
• neurovascular and oncological interventions
• Proving the value of automated interventional workflows for the staff, patients and the healthcare system
• Improving patient outcomes and support clinical decision-making

The Project Will Focus on Two Use Cases:

• Brain Aneurysms: AI-driven detection, risk prediction, and precise treatment planning
• Liver Tumors: Robotic-assisted thermal ablation for enhanced accuracy and efficiency

The SHERPA solution will serve as a reliable companion throughout the clinical workflow. The project will carry out seven clinical studies to validate its outputs. The SHERPA results and new standards in minimally invasive image-guided treatment will be transferrable to other medical specialties. The methodological framework will be made available as a standardized tool to be used widely in clinical study design.

Facts and Figures:

• Coordinator: Philips Image Guided Therapy
• Consortium: Philips Image Guided Therapy (NL), Philips France Commercial (FR), Medtronic Iberica (ES), Sim&Cure (FR), Isys Medizintechnik (AT), Barco (BE), Universitair Medisch Centrum Utrecht (NL), Universitaetsklinikum Hamburg-Eppendorf (DE), Assistance Publique Hopitaux de Paris (FR), Fundacio de Gestio Sanitaria de l‘Hospital de la Santa Creu i Sant Pau (ES), Cardiovascular and Interventional Radiological Society of Europe (AT), HFC Human-Factors-Consult (DE), Technische Universiteit Eindhoven (NL), European Institute for Biomedical Imaging Research (AT), Stichting Sint Antonius Ziekenhuis (NL), European Society of Minimally Invasive Neurological Therapy (CH)
• Runtime: January 1, 2025 – December 31, 2028
• Total Funding: €13.6 million

• LinkedIn